Neogen (NEOG) Free Cash Flow Growth (5y) (2015 - 2026)
Neogen (NEOG) Free Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Neogen | 2.61 Bn | 2.42 Bn | 107.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 12.33% |
| Feb 28, 2026 | 27.44% |
| Nov 30, 2025 | -12.94% |
| Aug 31, 2025 | -21.33% |
| May 31, 2025 | -54.50% |
| Feb 28, 2025 | -23.10% |
| Nov 30, 2024 | 17.26% |
| Aug 31, 2024 | -39.41% |
| May 31, 2024 | -32.73% |
| Feb 29, 2024 | -69.35% |
| Nov 30, 2023 | -22.37% |
| Aug 31, 2023 | -20.48% |
| May 31, 2023 | 29.60% |
| Feb 28, 2023 | -34.65% |
| Nov 30, 2022 | -67.65% |
| Aug 31, 2022 | -31.31% |
| May 31, 2022 | -10.29% |
| Feb 28, 2022 | -14.95% |
| Nov 30, 2021 | 16.50% |
| Aug 31, 2021 | 5.42% |